There is no such thing as a “US wet wipes regulation”. There are three, and which one applies to your product is decided by two things only: what you claim it does, and what is in it. Get either wrong and a shipment that cleared customs last year can be refused this year.
- Intended use decides the category. The product itself does not have a fixed regulatory identity.
- Cosmetic wipes need facility registration and product listing under MoCRA — but no premarket approval.
- Claiming a wipe kills germs on skin makes it a drug, with an NDC and cGMP obligations.
- Surface disinfecting wipes are regulated by EPA as pesticides, not by FDA.
- “Do Not Flush” labelling is a state-level patchwork with a federal standard still in progress.
Why the category matters more than the product
Most sourcing conversations start with material, GSM and pack format. In the US market, the question that decides whether the product can be sold at all comes earlier: what does the pack say it does?
The same wipe — same nonwoven, same lotion base, same flow pack — can be a cosmetic, a drug, or a pesticide depending on one line of copy. That is not a technicality. The three routes have different registrations, different labelling rules, different testing expectations and very different timelines.
| Path | Trigger | Regulator | Core obligation |
|---|---|---|---|
| Cosmetic | Cleans, moisturises, removes makeup, refreshes — no therapeutic claim | FDA (MoCRA) | Facility registration + product listing; no premarket approval |
| OTC drug | Claims to kill germs on skin, or to treat a skin condition | FDA (CDER) | OTC monograph compliance or NDA; NDC; drug cGMP |
| Pesticide | Claims to disinfect surfaces or kill germs on inanimate objects | EPA (FIFRA) | Full product registration before sale |
Path one: cosmetics
Baby wipes, facial cleansing wipes, makeup remover wipes, personal care and deodorising wipes sit here — provided nothing on the pack promises a therapeutic outcome.
Since the Modernization of Cosmetics Regulation Act (MoCRA), the compliance floor is higher than most suppliers realise. FDA delayed enforcement of the registration and listing provisions to 1 July 2024, and they now apply.
- No premarket approval. Apart from colour additives, a cosmetic does not need FDA clearance before it goes on sale. The brand carries full responsibility for safety and for label accuracy.
- Facility registration and product listing. Both are mandatory. A foreign manufacturing facility also needs a US agent.
- Label accuracy is the enforcement lever. FDA does not approve the label in advance — it acts afterwards, which means the risk sits with whoever signed the artwork.
- Ingredient restrictions vary by market. A preservative system accepted in one destination can be restricted in another. Formula transfer between markets is never a straight copy.
What exists is facility registration, product listing and ongoing enforcement. A supplier that offers you an “FDA certificate” for a baby wipe is describing something the agency does not issue. Treat the wording as a signal about how carefully the rest of the compliance work is being handled.
Path two: OTC drugs
Add a claim that the product kills bacteria on the skin, or treats a condition such as acne or nappy rash, and the wipe stops being a cosmetic. It becomes a drug, reviewed by FDA’s Center for Drug Evaluation and Research.
Alcohol-based sanitising wipes, benzalkonium chloride wipes and medicated skin wipes all enter through this door. The obligations change substantially:
- Monograph or NDA. If the active ingredient sits inside an applicable FDA OTC monograph, and meets its specified concentration and labelling format, no new drug application is required. Outside the monograph, the route becomes an NDA.
- NDC. The product needs a National Drug Code, and it must appear on the pack in the prescribed format.
- Drug cGMP. The manufacturing facility must be registered and must operate to drug good manufacturing practice — a heavier standard than cosmetic production.
- Efficacy evidence. Claims of microbial kill need supporting test data for the organisms named on the label.
Path three: surface disinfectants, and why they go to EPA
Wipes that disinfect worktops, floors, bathrooms or other inanimate surfaces are not FDA products at all. Under the Federal Insecticide, Fungicide and Rodenticide Act, a product that claims to kill or reduce micro-organisms on a surface is a pesticide, and it must be registered with the EPA before it can be sold.
This is the slowest and most expensive of the three routes, and it is the one most often underestimated at quotation stage. EPA registration is not a paperwork exercise — it involves efficacy data, chemistry review and a registration process measured in months, not weeks.
Adding “kills 99.9% of germs” to a pack that was built as a cosmetic wipe. The words are a claim, the claim sets the category, and the category you have just entered requires an EPA registration you do not hold. Goods get held, relabelled or destroyed — and the printed film is waste.
The label decides the category
Because intended use is established by claims, the artwork proof is the real regulatory checkpoint in this category. Not the formulation sheet, not the purchase order — the proof.
Three practical consequences for the sourcing conversation:
- Claims get signed off before print, not after. Whoever approves the copy is approving the regulatory route.
- Cross-category claims are the failure mode. A cleaning wipe that also says “antibacterial” may be claiming a pesticide function. A baby wipe that says “protects against rash” may be claiming a drug function.
- One pack cannot serve two routes. If you want cosmetic and disinfecting versions of the same SKU, they are two products with two sets of artwork and two compliance files.
“Do Not Flush” is now its own compliance track
Separately from the FDA and EPA question, non-flushable wipes now face labelling requirements aimed at wastewater systems. Several US states have introduced their own “Do Not Flush” rules, and the resulting patchwork is the practical problem for anyone distributing nationally: complying with the strictest state is currently the only safe default.
A federal bill — the WIPPES Act — has been moving through Congress to replace that patchwork with a single national standard. Until it takes effect, the state rules are what you actually have to meet, so the artwork should be designed for the strictest one you ship into.
Note the distinction that matters commercially: flushable is a performance claim about how the product disperses, while “Do Not Flush” is a labelling obligation for products that do not. They are not interchangeable, and carrying one does not satisfy the other.
What to lock down before artwork
Six items to settle with your supplier before film goes to print:
- The exact claim set, written out in full, and the regulatory route each claim implies
- Whether any claim crosses into drug or pesticide territory
- Facility registration and product listing completed, with a US agent appointed
- Active ingredients checked against the applicable OTC monograph, if the drug route applies
- NDC format on pack, if the product is a drug
- “Do Not Flush” wording and symbol present, to the strictest state standard in your distribution footprint
None of this is expensive at the artwork stage. All of it is expensive after print.
Frequently asked questions
Is a baby wipe a cosmetic or a drug in the US?
A cosmetic, as long as it only cleans and moisturises. Add a therapeutic claim — treating or preventing nappy rash, for example — and the classification changes.
Can the same factory produce cosmetic and disinfecting wipes?
Yes, and most do. What cannot be shared is the compliance position: the disinfecting line needs EPA registration and its own labelling, and the two product types should not be presented as variants of one SKU.
Does a cosmetic wipe need FDA approval before sale?
No. Apart from colour additives there is no premarket approval. The obligations are facility registration, product listing, and responsibility for safety and label accuracy.
What changes if we export to the EU instead?
A different framework entirely. Cosmetics follow the EU Cosmetics Regulation with CPNP notification, and disinfecting wipes fall under the Biocidal Products Regulation rather than FIFRA. A US-compliant label will not carry across without rework.
Building a US launch?
Send us your proposed claims and pack format. We will tell you which regulatory route the wording puts you on, before you commit to printing plates.
This article summarises the US requirements as we understand them for commercial planning purposes. It is not legal advice. Confirm the current text of MoCRA, FIFRA and applicable state labelling rules, and your own obligations, with your regulatory adviser.